Invicol GmbH is a MedTech start-up located in the CoLaborator of the Bayer AG in Berlin, where we are developing the BMProbe. The Probe is inserted into the patients’ cubital vein for the isolation of rare circulating cells. The minimally invasive approach has a high sensitivity and specificity providing compelling and improved diagnostic value. Our technology opens new possibilities in the field of personalized medicine, early diagnosis and disease monitoring.
